(3beta)-3-Hydroxyandrost-4-en-17-one(CAS: 571-44-8)

The compound (3beta)-3-Hydroxyandrost-4-en-17-one (CAS: 571-44-8) is subject to various regulatory guidelines, including GHS classification for hazardous substances, REACH regulations in the EU, and FDA/EPA requirements for safety and environmental impact. It is important to comply with local and international regulations to ensure safe handling and disposal.

Alternative reagents and isomers can be used in the synthesis of (3beta)-3-Hydroxyandrost-4-en-17-one (CAS: 571-44-8). Common alternatives include (3alpha)-3-Hydroxyandrost-4-en-17-one and other related androstane derivatives. These alternatives offer similar functionalities but may differ in synthesis complexity and cost.

The market for (3beta)-3-Hydroxyandrost-4-en-17-one (CAS: 571-44-8) is growing due to increasing research in androstane derivatives for pharmaceutical applications. Recent trends show a focus on developing new analogs and isomers that can be used as potential drug candidates. Additionally, there is a rising interest in the compound's potential use in hormone therapy and hormone-based treatments.

Waste containing (3beta)-3-Hydroxyandrost-4-en-17-one (CAS: 571-44-8) should be collected and handled according to local and international regulations. Proper waste collection methods include using appropriate containers, ensuring containment to prevent spillage, and labeling the waste as hazardous. For final disposal, incineration or professional waste disposal services should be utilized, and environmental protection measures should be taken to minimize environmental impact.